Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × saxagliptin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

Metformin 145 Clomiphene 50 Letrozole 38 Inositol 32 Folic Acid 18 Exercise 17 Progesterone 15 Ethinyl Estradiol 13 Chorionic Gonadotropin 13 Caloric Restriction 13 drospirenone and ethinyl estradiol combination 12 Estradiol 12 Contraceptives, Oral 11 cetrorelix 10 High-Intensity Interval Training 10 Tablets 9 Spironolactone 9 Pioglitazone 9 Cholecalciferol 9 Triptorelin Pamoate 8 Diet 8 Vitamin D 7 Thioctic Acid 7 Menotropins 7 Liraglutide 7 Acupuncture Therapy 7 drospirenone 6 Ovidrel 6 Gonadotropins 6 Flutamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02022007 2017-06-28

BMS-AZPCOS

Woman's

Phase 3 Completed

38 enrolled 17 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡